Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants [Phase 2]

View source ↗

Summary

A Phase 2 study assessing safety, tolerability, and pharmacokinetics of cefiderocol in hospitalized pediatric participants has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bloodstream Infection
• Complicated Intra-abdominal Infection
• Complicated Urinary Tract Infection
• Hospital-acquired Pneumonia
• Sepsis
• Ventilator-associated Pneumonia

Drugs mentioned

• Fetroja (cefiderocol)

Snippet

Sponsor: Shionogi | Conditions: Gram-negative Bacterial Infections, Bloodstream Infections (BSI) | Phase 2 | Status: COMPLETED | Results posted: 2026-02-27